Research on the mechanism of the occurrence and prognosis of differentiated thyroid carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058347

Enrollment

Unknown

Registered

2022-04-07

Start date

2022-04-11

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated thyroid carcinoma

Interventions

Gold Standard:Pathology after surgery

Index test:Ultrasound, gene detection, RNA sequencing, mass spectrometry

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged >=18 years; 2. Papillary thyroid carcinoma was confirmed by surgery and pathology.

Exclusion criteria

Exclusion criteria: 1. Complicated with other malignant tumors or had received neck surgery or had a history of neck radiation; 2. Pregnant and lactating patients; 3. Patients with coagulopathy, serious cardiopulmonary disease or other patients who cannot tolerate surgical treatment.

Design outcomes

Primary

Measure	Time frame
gene detection;RNA sequencing;mass spectrometry;	—

Countries

China

Contacts

Public ContactLuo Yukun

shawyjs@163.com+86 10 66939533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026